# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-082027
Filing Date
2025-08-29
Accepted
2025-08-28 21:47:52
Documents
118
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0254438-20f_alterity.htm iXBRL | 20-F | 2004808
2 | CERTIFICATION | ea025443801ex12-1_alterity.htm | EX-12.1 | 10049
3 | CERTIFICATION | ea025443801ex12-2_alterity.htm | EX-12.2 | 10110
4 | CERTIFICATION | ea025443801ex13-1_alterity.htm | EX-13.1 | 4204
5 | CERTIFICATION | ea025443801ex13-2_alterity.htm | EX-13.2 | 4115
6 | CONSENT OF PRICEWATERHOUSECOOPERS | ea025443801ex15-1_alterity.htm | EX-15.1 | 1541
7 | AUDITOR'S INDEPENDENCE DECLARATION | ea025443801ex15-2_alterity.htm | EX-15.2 | 658
8 | GRAPHIC | image_001.jpg | GRAPHIC | 99644
| Complete submission text file | 0001213900-25-082027.txt |  | 8947177

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | athe-20250630.xsd | EX-101.SCH | 108843
10 | XBRL CALCULATION FILE | athe-20250630_cal.xml | EX-101.CAL | 48900
11 | XBRL DEFINITION FILE | athe-20250630_def.xml | EX-101.DEF | 355566
12 | XBRL LABEL FILE | athe-20250630_lab.xml | EX-101.LAB | 675230
13 | XBRL PRESENTATION FILE | athe-20250630_pre.xml | EX-101.PRE | 381507
121 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0254438-20f_alterity_htm.xml | XML | 1376965

Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 251275682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)